SGMO certainly qualifies as a hot biotech. Very strong moves with no news. They will be touting some interesting phase 1 starts in brain cancer and HIV in a couple months. There might also be some phase 2 results by year end for their first drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.